The Brigham Innovations and New Practices in Internal Medicine 2026
$16.00
Skip to product information
The Brigham Innovations and New Practices in Internal Medicine 2026
$16.00
Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026
The Brigham Internal Medicine 2026 | Harvard Medical School Faculty, Cardiology, Diabetes, Obesity, Infectious Diseases, Gastroenterology, Nephrology, Pulmonology, Geriatrics, AI & Clinical Practice Updates
The Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026 provides a comprehensive, evidence-based educational update on emerging clinical developments, new treatment strategies, diagnostic advances, and evolving practice guidelines across the major specialties of internal medicine. Produced by Oakstone Publishing (CMEinfo) with educational content from Brigham and Women's Hospital, this program brings together expert Harvard Medical School faculty to examine important innovations affecting everyday clinical practice. Originally released on August 31, 2026, this educational video program addresses recent advances in cardiovascular medicine, diabetes, obesity, infectious diseases, gastroenterology, hepatology, nephrology, pulmonary medicine, rheumatology, geriatrics, neurology, women's health, preventive medicine, and primary care. The Brigham Innovations and New Practices in Internal Medicine 2026 curriculum emphasizes practical application of current evidence, diagnostic reasoning, individualized treatments, and evidence-based clinical decision-making. The program also examines rapidly developing areas of contemporary medicine, including artificial intelligence and ChatGPT, longevity science, emerging obesity medications, diabetes technology, health equity, cannabinoid medicine, opioid use disorder, HIV prevention, and new cardiovascular therapies. Rather than focusing exclusively on traditional disease reviews, the program explores what has changed in internal medicine and how these developments can be incorporated into patient care. Clinical presentations and case-based discussions help clinicians evaluate new evidence, understand evolving medical recommendations, and integrate contemporary treatment options into practice.Course Details
- Course: Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026
- Official Program: The Brigham Internal Medicine: Innovations and New Practices
- Content Institution: Brigham and Women's Hospital
- Academic Affiliation: Harvard Medical School
- Publisher: Oakstone Publishing / CMEinfo
- Original Live Course: May 11–15, 2026
- Original Video Release: August 31, 2026
- Original CME Credit Expiration: August 30, 2029
- Format: Online Video Educational Program
- Primary Specialty: Internal Medicine
- Additional Focus: Hospital Medicine, Primary Care, Cardiology, Endocrinology, Gastroenterology, Nephrology, Pulmonology, Neurology, Infectious Diseases, Rheumatology, Geriatrics and Women's Health
- Language: English
- Course Directors: Ole-Petter R. Hamnvik, MB BCh BAO, MMSc, and Colleen A. Monaghan, MD
- Official AMA CME: Up to 33.5 AMA PRA Category 1 Credits™
- Official ABIM MOC: Up to 33.5 Points
- Educational Approach: Expert Video Lectures, Clinical Cases, Evidence-Based Reviews and Practice-Focused Updates
Target Audience
The program is designed for healthcare professionals seeking practical updates on contemporary internal medicine. The target audience includes:- Internal Medicine Physicians
- General Internists
- Hospitalists
- Primary Care Physicians
- Family Medicine Physicians
- General Practitioners
- Cardiologists
- Endocrinologists
- Gastroenterologists
- Nephrologists
- Pulmonologists
- Infectious Disease Physicians
- Geriatricians
- Rheumatologists
- Neurologists
- Advanced Practice Providers
- Physician Assistants
- Nurse Practitioners
- Medical Residents
- Clinical Fellows
- Other Healthcare Professionals Involved in Adult Medical Care
Program Overview
Internal medicine continues to evolve as new clinical evidence, medical technologies, treatments, and guidelines influence healthcare delivery. Physicians must interpret these developments while managing patients with complex medical conditions, multimorbidity, and competing treatment priorities. The Brigham Internal Medicine 2026 program addresses these challenges through an extensive review of recent innovations and their practical implications. The curriculum covers:- Heart Failure Treatment
- Atrial Fibrillation
- Valvular Heart Disease
- Cardiovascular Risk Reduction
- Lipid-Lowering Therapy
- Anticoagulation
- Hypertension
- Diabetes Technology
- Diabetes Treatment Guidelines
- Obesity Medications
- Dietary Obesity Management
- Primary Aldosteronism
- Thyroid Disorders in Pregnancy
- Bone Health
- Metabolic Dysfunction-Associated Steatotic Liver Disease
- GERD and Barrett's Esophagus
- Helicobacter pylori
- Irritable Bowel Syndrome
- Chronic Kidney Disease
- Antimicrobial Stewardship
- Vaccinations
- Sexually Transmitted Infections
- HIV Prevention
- Doxy-PEP
- Asthma
- COPD
- Headache Disorders
- Stroke Management
- Dementia and Alzheimer's Disease
- Longevity Science
- Geriatric Medicine
- Rheumatology
- Gout and Crystal Deposition Disease
- Menopause Management
- Gynecologic Cancer Screening
- Pelvic Floor Disorders
- Cancer Screening
- Dermatology
- Depression and Anxiety
- Opioid Use Disorder
- Artificial Intelligence in Medicine
- Health Equity
- Exercise and Preventive Medicine
Learning Objectives
After completing the original educational program, participants should be better able to:- Interpret current evidence and emerging clinical developments relevant to internal medicine practice.
- Apply current clinical guidelines and evidence-based recommendations to the evaluation and management of common and complex medical conditions.
- Apply updated diagnostic and clinical reasoning strategies to evaluate challenging patient presentations.
- Integrate contemporary pharmacologic, procedural, technological, and nonpharmacologic treatments into individualized management plans.
- Deliver equitable, inclusive, and patient-centered care that considers race, ethnicity, sex, gender identity, sexual orientation, disability status, and other individual patient factors.
Complete 2026 Course Curriculum
The following lectures and faculty are organized by clinical specialty for easier review. This organization is based on the supplied course curriculum rather than a claim that the recordings are arranged in this exact sequence.Session I – Cardiology and Cardiovascular Medicine
Treatment of Heart Failure in 2026
Faculty: Anju Nohria, MD, MSc Reviews contemporary developments in heart failure diagnosis and treatment. Important clinical considerations include:- Heart Failure Classification
- Heart Failure With Reduced Ejection Fraction
- Heart Failure With Preserved Ejection Fraction
- Guideline-Directed Medical Therapy
- SGLT2 Inhibitors
- Volume Management
- Risk Stratification
- New Treatment Strategies
Atrial Fibrillation
Faculty: Paul C. Zei, MD, PhD, FHRS, FACC Examines current approaches to atrial fibrillation management. Important topics include:- Atrial Fibrillation Diagnosis
- Rate Control
- Rhythm Control
- Stroke Prevention
- Anticoagulation
- Catheter Ablation
- Patient Risk Assessment
- Individualized Treatment Selection
Percutaneous Approaches to Valvular Disease
Faculty: Pinak B. Shah, MD Reviews advances in catheter-based treatment of valvular heart disease. Relevant areas include:- Aortic Valve Disease
- Mitral Valve Disease
- Transcatheter Valve Interventions
- Patient Selection
- Structural Heart Disease
- Procedural Risk
- Multidisciplinary Valve Care
Recent Advances in Lipid Therapy and Cardiovascular Risk Reduction
Faculty: Pradeep Natarajan, MD, MMSc Examines contemporary approaches to lipid management and cardiovascular prevention. Important considerations include:- LDL Cholesterol Reduction
- Atherosclerotic Cardiovascular Disease
- Risk Stratification
- Statin Therapy
- Non-Statin Lipid Treatments
- Emerging Lipid-Lowering Agents
- Cardiovascular Prevention
Thrombosis and Anticoagulation
Faculty: Gregory Piazza, MD, MS Reviews developments in thrombotic disease and anticoagulant therapy. Topics include:- Venous Thromboembolism
- Deep Vein Thrombosis
- Pulmonary Embolism
- Direct Oral Anticoagulants
- Bleeding Risk
- Anticoagulation Management
- Treatment Duration
Best Practices in Hypertension Management
Faculty: Romela Petrosyan, MD, SM, FASN, FACP Examines evidence-based approaches to hypertension. Important areas include:- Blood Pressure Assessment
- Cardiovascular Risk
- Hypertension Guidelines
- Pharmacological Treatment
- Resistant Hypertension
- Secondary Hypertension
- Individualized Treatment Goals
Aging and the Cardiovascular System
Faculty: Ami Bhatt, MD Reviews cardiovascular changes associated with aging. Important considerations include:- Cardiovascular Aging
- Vascular Function
- Cardiac Structure
- Age-Related Cardiovascular Risk
- Functional Assessment
- Preventive Strategies
- Clinical Management
Session II – Diabetes, Endocrinology and Obesity Medicine
Thyroid Disease in Pregnancy
Faculty: Athanasios Bikas, MD, PhD Examines thyroid disorders during pregnancy, including diagnostic assessment, maternal-fetal considerations, and treatment planning.Advances in Diabetes Technology
Faculty: Nadine E. Palermo, DO Reviews developments in continuous glucose monitoring, insulin delivery technologies, and technology-supported diabetes management.Bone Health in 2026
Faculty: Sharon H. Chou, MD Examines osteoporosis, bone health assessment, fracture prevention, and evolving treatment strategies.Diabetes Management – New Drugs, Approaches, and Guidelines
Faculty: Marie E. McDonnell, MD Reviews contemporary diabetes medications, treatment guidelines, cardiovascular and renal considerations, and individualized glycemic management.Dietary Approaches to Obesity Management
Faculty: Chika V. Anekwe, MD, MPH Explores dietary interventions, nutritional planning, weight management, and evidence-based lifestyle strategies for obesity treatment.Primary Aldosteronism
Faculty: Anand Vaidya, MD, MMSc Reviews recognition, screening, diagnosis, and treatment considerations for primary aldosteronism as a cause of secondary hypertension.What’s New in Obesity Medications, Devices, and Procedures
Faculty: Priya Jaisinghani, MD, DABOM Examines newer pharmacologic, device-based, and procedural approaches to obesity management. Topics of clinical relevance include:- Anti-Obesity Medications
- Incretin-Based Therapies
- GLP-1 Receptor Agonists
- Patient Selection
- Treatment Safety
- Weight-Loss Outcomes
- Obesity Procedures
- Long-Term Weight Management
Session III – Gastroenterology and Hepatology
Update in MASLD
Faculty: M. Valerie Lin, MD Reviews metabolic dysfunction-associated steatotic liver disease, including risk assessment, noninvasive evaluation, metabolic risk factors, and treatment considerations.Updates in Upper Gastrointestinal Disorders: GERD, Barrett’s Esophagus, and H. pylori
Faculty: Molly L. Perencevich, MD Examines updated approaches to upper gastrointestinal conditions. Important topics include:- Gastroesophageal Reflux Disease
- Barrett's Esophagus
- Helicobacter pylori
- Diagnostic Testing
- Medical Management
- Surveillance
- Treatment Selection
What’s New in Irritable Bowel Syndrome
Faculty: Kyle D. Staller, MD, MPH Reviews current developments in irritable bowel syndrome diagnosis and treatment, including symptom-based evaluation, therapeutic selection, dietary considerations, and patient-centered management.Session IV – Infectious Diseases
Hot Topics in Infectious Diseases
Faculty: Sarah P. Hammond, MD Examines emerging infectious disease developments and clinically important updates relevant to internal medicine.Responsible Use of Antibiotics
Faculty: Paul E. Sax, MD Reviews antimicrobial stewardship and appropriate antibiotic prescribing. Topics include:- Antibiotic Selection
- Antimicrobial Resistance
- Diagnostic Stewardship
- Avoiding Unnecessary Treatment
- Treatment Duration
- Patient Safety
Update on Immunizations
Faculty: Daniel A. Solomon, MD, FIDSA Reviews current vaccination strategies, immunization recommendations, adult preventive care, and special population considerations.Update on STIs, PrEP, and Doxy PEP
Faculty: Kevin L. Ard, MD, MPH Examines contemporary approaches to sexually transmitted infection prevention and management. Important topics include:- STI Screening
- HIV Prevention
- Pre-Exposure Prophylaxis
- Doxycycline Post-Exposure Prophylaxis
- Risk Assessment
- Preventive Counseling
- Evidence-Based Recommendations
Session V – Nephrology
What’s New, Innovative, and Controversial in Chronic Kidney Disease
Faculty: J. Kevin Tucker, MD Reviews emerging evidence and current clinical controversies in chronic kidney disease management. Important considerations include:- Chronic Kidney Disease
- Kidney Function Assessment
- Albuminuria
- Cardiovascular Risk
- Renal-Protective Treatments
- CKD Progression
- Treatment Guidelines
- Individualized Patient Management
Session VI – Geriatric Medicine, Aging and Longevity
Longevity Overview
Faculty: Julia V. Loewenthal, MD Introduces important concepts in longevity medicine, healthy aging, and the interpretation of emerging evidence related to aging interventions.Longevity Keynote – Aging and Longevity for the Internist: Why and Why Now?
Faculty: Louise Aronson, MD, MFA Explores the relevance of longevity science and aging-related healthcare to contemporary internal medicine.Aging Biomarkers
Faculty: Lewis A. Lipsitz, MD Examines biological markers associated with aging, their potential applications, and limitations in clinical interpretation.Longevity Cases
Faculty:- Julia V. Loewenthal, MD
- Jay R. Luthar, MD, DipABLM
Update in Geriatrics – The Latest Studies and Their Clinical Relevance
Faculty: Suzanne E. Salamon, MD Reviews important recent geriatric medicine research and its implications for the care of older adults.Update in Dementia and Alzheimer's Disease
Faculty: Gad A. Marshall, MD Examines developments in dementia diagnosis, cognitive assessment, Alzheimer's disease, disease-modifying treatments, and patient management.Session VII – Rheumatology
Update in Rheumatology
Faculty: Eli M. Miloslavsky, MD Reviews important developments in inflammatory and autoimmune rheumatological disorders. Topics may inform clinical evaluation, diagnosis, treatment selection, and ongoing disease monitoring.Advances in Gout and Crystal Deposition Disease
Faculty: Sara K. Tedeschi, MD, MPH Examines recent developments in gout and related crystal deposition diseases. Important considerations include:- Gout
- Hyperuricemia
- Crystal Arthritis
- Urate-Lowering Therapy
- Acute Flare Management
- Diagnostic Evaluation
- Long-Term Disease Control
Session VIII – Pulmonary Medicine
Asthma Update
Faculty: Elliot Israel, MD, MSc (Hon) Reviews developments in asthma diagnosis, treatment selection, inhaled therapies, biologic treatment considerations, and individualized disease management.Update in COPD
Faculty: Craig P. Hersh, MD, MPH Examines contemporary chronic obstructive pulmonary disease management. Important topics include:- COPD Assessment
- Exacerbation Risk
- Bronchodilator Therapy
- Inhaled Treatments
- Preventive Care
- Smoking Cessation
- Long-Term Management
Session IX – Neurology
Advances in Diagnosis and Management of Headache
Faculty: Carolyn A. Bernstein, MD, FAHS Reviews advances in headache assessment and treatment, including migraine evaluation, preventive therapies, and individualized treatment strategies.Stroke Management in 2026
Faculty: Alexis T. Roy, MD, MSc Examines contemporary approaches to stroke assessment, treatment, secondary prevention, and multidisciplinary management.Session X – Women's Health
Pelvic Floor Disorders – Medical Management and More
Faculty: Neeraj Kohli, MD, MBA Reviews pelvic floor dysfunction, urinary symptoms, clinical evaluation, conservative management, and treatment considerations.Gynecologic Cancer Screening
Faculty: Colleen M. Feltmate, MD Examines current screening approaches, cancer risk assessment, preventive strategies, and appropriate referral considerations.Update in Menopause Management
Faculty: Deborah Gomez Kwolek, MD, FACP, MSCP, FAMWA Reviews clinical developments in menopause management. Important topics include:- Menopausal Symptoms
- Hormonal Therapy
- Non-Hormonal Treatment
- Treatment Safety
- Long-Term Women's Health
- Individualized Clinical Decisions
Session XI – Primary Care and General Internal Medicine
Clinical Cases in Dermatology
Faculty: Adam D. Lipworth, MD Reviews common and challenging dermatological presentations through clinical cases, emphasizing recognition, differential diagnosis, and appropriate management.Cancer Screening Cases
Faculty: Leigh H. Simmons, MD Examines practical cancer screening decisions using case-based examples. Important considerations include screening eligibility, risk assessment, preventive counseling, and interpretation of recommendations.Depression and Anxiety
Faculty: David S. Kroll, MD Reviews assessment and treatment of depression and anxiety in medical practice. Topics include diagnostic evaluation, pharmacological therapy, nonpharmacological approaches, and longitudinal care.Best Practices for Preoperative Evaluation
Faculty: Adam C. Schaffer, MD, MPH Examines evidence-based preoperative assessment and optimization. Important considerations include:- Perioperative Risk
- Cardiovascular Evaluation
- Medication Management
- Comorbid Conditions
- Surgical Preparation
- Appropriate Testing
Exercise for Health – What’s New in 2026
Faculty: Meagan M. Wasfy, MD, MPH Reviews the role of physical activity in health promotion, cardiovascular prevention, chronic disease management, and personalized exercise recommendations.Session XII – Emerging and Innovative Areas of Medicine
Innovations in Cannabinoid Medicine
Faculty: Jordan Tishler, MD Examines contemporary evidence, clinical controversies, potential therapeutic applications, and safety considerations involving cannabinoid medicine.Advancing Patient Equity in Medicine
Faculty: Bram P. Wispelwey, MD, MS, MPH Reviews approaches to improving equity in healthcare. Important themes include:- Healthcare Disparities
- Access to Care
- Inclusive Clinical Practice
- Social Determinants of Health
- Patient-Centered Care
- Quality Improvement
AI and ChatGPT
Faculty: Rebecca G. Mishuris, MD, MS, MPH, FAMIA Explores the use of artificial intelligence and generative AI in clinical medicine. Important considerations include:- Clinical Decision Support
- Generative Artificial Intelligence
- Documentation
- Healthcare Workflows
- AI Reliability
- Patient Safety
- Bias
- Human Oversight
- Appropriate Clinical Applications
Management of Opioid Use Disorder
Faculty: Joji Suzuki, MD Reviews evidence-based approaches to opioid use disorder, including clinical assessment, medication treatment, harm reduction, relapse prevention, and coordinated care.Major Topics Covered
- The Brigham Internal Medicine 2026
- Innovations and New Practices in Internal Medicine
- Harvard Medical School Faculty
- Evidence-Based Internal Medicine
- Clinical Practice Updates
- Heart Failure
- Atrial Fibrillation
- Valvular Heart Disease
- Lipid Management
- Cardiovascular Risk Reduction
- Thrombosis
- Anticoagulation
- Hypertension
- Diabetes Technology
- Continuous Glucose Monitoring
- Diabetes Management
- Obesity Medicine
- Anti-Obesity Medications
- Thyroid Disease in Pregnancy
- Osteoporosis
- Bone Health
- Primary Aldosteronism
- MASLD
- GERD
- Barrett's Esophagus
- Helicobacter pylori
- Irritable Bowel Syndrome
- Chronic Kidney Disease
- Infectious Diseases
- Antibiotic Stewardship
- Immunizations
- HIV PrEP
- Doxy-PEP
- Geriatric Medicine
- Longevity
- Aging Biomarkers
- Alzheimer's Disease
- Dementia
- Rheumatology
- Gout
- Crystal Deposition Disease
- Asthma
- COPD
- Headache Disorders
- Stroke
- Pelvic Floor Disorders
- Menopause
- Cancer Screening
- Dermatology
- Depression and Anxiety
- Preoperative Evaluation
- Exercise Medicine
- Cannabinoid Medicine
- Health Equity
- Artificial Intelligence
- ChatGPT in Medicine
- Opioid Use Disorder
- Patient-Centered Care
Cardiovascular Medicine and Risk Reduction
Cardiovascular disease remains a major area of clinical decision-making in internal medicine. The program examines treatment developments involving heart failure, atrial fibrillation, hypertension, thrombosis, lipid abnormalities, and valvular heart disease. These educational sessions support clinical understanding of evolving evidence and the appropriate selection of patient-specific cardiovascular treatments.Diabetes, Obesity and Metabolic Medicine
Advances in diabetes technology and obesity management continue to influence treatment approaches across internal medicine. The course reviews newer pharmacological therapies, diabetes technologies, nutritional strategies, and other interventions relevant to metabolic disease. The curriculum also addresses primary aldosteronism, thyroid disease during pregnancy, osteoporosis, and metabolic liver disease.Gastroenterology, Hepatology and Kidney Disease
Common gastrointestinal, hepatic, and renal disorders frequently require long-term medical management. The program includes updates involving MASLD, GERD, Barrett's esophagus, H. pylori infection, irritable bowel syndrome, and chronic kidney disease. The educational focus emphasizes diagnostic reasoning, current evidence, risk assessment, and individualized treatment decisions.Infectious Diseases and Preventive Medicine
The infectious disease curriculum addresses important clinical developments affecting outpatient and hospital medicine. Major topics include antimicrobial stewardship, vaccination, STI prevention, HIV PrEP, Doxy-PEP, and emerging infectious disease issues. These sessions are relevant to clinicians responsible for antimicrobial prescribing, preventive counseling, and infection management.Healthy Aging, Longevity and Dementia
Aging and longevity are major educational themes of the 2026 program. The curriculum examines:- Healthy Aging
- Longevity Science
- Aging Biomarkers
- Cardiovascular Aging
- Geriatric Research
- Alzheimer's Disease
- Dementia Management
- Older Adult Care
Clinical Reasoning and Evidence-Based Care
An important theme throughout the program is translating scientific advances into daily medical practice. Clinicians are encouraged to integrate:- Current Research
- Diagnostic Assessment
- Clinical Guidelines
- Individual Patient Characteristics
- Pharmacologic Therapies
- Procedural Treatments
- Medical Technologies
- Nonpharmacologic Interventions
- Shared Decision-Making
Artificial Intelligence and Emerging Clinical Technologies
Artificial intelligence is an increasingly prominent area of healthcare innovation. The curriculum includes a dedicated presentation addressing AI and ChatGPT. Relevant considerations include potential benefits for clinical workflows, decision support, documentation, education, and information management, alongside the need for accuracy, safety, privacy, and clinician oversight.Course Leadership
Ole-Petter R. Hamnvik, MB BCh BAO, MMSc
- Associate Professor of Medicine, Harvard Medical School
- Program Director, Endocrinology Fellowship, Brigham and Women's Hospital
- Education Editor, NEJM Group
Colleen A. Monaghan, MD
- Assistant Professor of Medicine and Pediatrics, Harvard Medical School
- Associate Medical Director, Brigham and Women's Primary Care
- Associate Program Director, Harvard Medicine-Pediatrics Residency
Continuing Medical Education
The original Oakstone educational activity provides up to:- 33.5 AMA PRA Category 1 Credits™
- 33.5 ABIM Maintenance of Certification Points
Important CME Notice
Purchasing separately distributed educational files through MedicalAmboss does not itself provide:- Official Oakstone CME Credits
- ABIM MOC Points
- Official Certificates
- Oakstone Course Registration
- Publisher Subscription Access
- Official Online Platform Access
- Publisher Accounts
- Publisher-Hosted Benefits